Skip to content Skip to footer

Jena Sophia on Breaking the Stress Code: Rewiring High Performance from Within 

Shots:  High performers often operate under a hidden layer of chronic stress, where sustained pressure subtly erodes decision-making, creativity, and emotional regulation, as subconscious patterns and past experiences continuously trigger a low-grade fight-or-flight response that impacts both performance and overall wellbeing  Lasting stress management requires going beyond surface-level techniques to address deep-rooted subconscious programming, where beliefs around identity, success,…

Read more

Innovation Meets Impact: Jaime Leija on BioLab’s Patient-First Approach

Shots:  BioLab balances innovation with real-world impact through a dual strategy that combines rapid commercialization of FDA-approved or near-market solutions like Imbed with continued investment in long-term innovations such as cureVision and terraplasma, ensuring both immediate clinical needs and future breakthroughs in wound care are effectively addressed.    BioLab’s growth is driven by sharp strategic discipline, focusing on chronic outpatient…

Read more

DeepCyte Secures $1.5M to Advance AI-Driven Single-Cell Toxicology in Drug Development

Shots: DeepCyte, a techbio startup focused on advancing AI-powered toxicology for drug development, has officially launched with $1.5 million in seed funding, introducing two solutions to help biopharma teams detect, predict, and understand drug toxicity in human cells at single-cell resolution DeepCyte's MetaCore, a high-throughput single-cell metabolomics platform, leverages laser-based sampling and mass spectrometry to…

Read more

PharmaShots Magazine-April-2026 Edition

Shots: AI is redefining compliance from reactive to predictive, as this April edition highlights how AI-powered systems are transforming regulatory oversight into a continuous, real-time, and data-driven function, enabling early risk detection, automated audits, and smarter regulatory collaboration across the pharma value chain. Strategic dealmaking and AI partnerships shape industry momentum, with March witnessing high-value…

Read more

PharmaShots Quarterly Outlook: The Forces Reshaping Biopharma in Q1 2026 

Headlines, Trends, and the Signals Shaping the Future of Biopharma  A Quarter That Reset the Biopharma Narrative  The first quarter of 2026 did not simply continue the momentum of the global biopharmaceutical industry; it redefined its direction.  From multi-billion-dollar acquisitions and accelerating rare disease breakthroughs to AI-powered discovery collaborations and gene therapy approvals, the industry demonstrated a clear shift toward precision innovation, strategic consolidation, and next-generation…

Read more

Reimagining Migraine Treatment: Alon Ironi of Theranica on Nerivio’s Journey to Nationwide Coverage 

Shots:  What started as a father’s determination to find a better solution has grown into a widely reimbursed therapy. Along the way, strong clinical evidence, early physician support, and carefully designed payer pilots helped unlock nationwide coverage, reaching nearly 130 million lives across Blue Cross Blue Shield plans.  In this conversation, Alon explains how Nerivio’s dual acute and preventive…

Read more

From Denials to Decisions: Dr. Wael Khouli of Authsnap on AI-Powered Healthcare Appeals 

Shots:  Did you know that nearly 15–20% of healthcare claims in the U.S. are denied on first submission, creating billions of dollars in administrative costs and forcing providers into complex, time-consuming appeals processes that strain revenue cycles, clinical staff, and patient care continuity?    Authsnap is an AI healthcare technology company helps providers manage insurance denials and…

Read more

PharmaShots Magazine-March-2026 Edition

Shots AI is transforming clinical trial oversight from periodic monitoring to continuous, real-time intelligence, enabling early detection of safety signals, protocol deviations, and operational risks while strengthening data integrity and patient protection. Advanced analytics and machine learning are powering predictive, risk-based monitoring, integrating data from decentralized trials, wearables, ePROs, and multiple clinical systems to prioritize…

Read more

ISPE Singapore Conference & Exhibition 2026 | August 19-21 | Suntec Singapore

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. The annual meeting highlights best practices and services – from manufacturing facility design to finished product. Whether joining onsite in Singapore or on-demand, this is your opportunity to gather the latest updates and…

Read more

Bridging Innovation and Clinical Reality: Shalabh Gupta, CEO of Unicycive Therapeutics, on the Future of Biotech

Shots  Cross-industry lessons from technology, design thinking, and startups can reshape drug development by encouraging faster iteration, disciplined decision-making, and a stronger focus on real patient needs, unlocking innovations that traditional biotech models may overlook.    Clinical experience and thoughtful engagement with the U.S. Food and Drug Administration highlight the importance of patient insights, transparent…

Read more